12 January 2026

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

12 January 2026 | n=29

  1. Kulchynska R, Sazonova Y, Azarskova M, Salyuk T, et al.
    Sex disparities and partners' positive HIV status in HIV recent infection among people who inject drugs in Ukraine.
    AIDS 2026.

  2. Filip I.
    HIV-specific screening strategies may enhance detection of liver fibrosis in high-risk individuals.
    AIDS 2026.

  3. Duarte MJ, Tien PC, Kardashian A, Ma Y, et al.
    Erratum: Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV.
    AIDS 2026;40:132.

  4. Brown MJ, Murtala NM, Amoatika D, Kaur A, et al.
    Erratum: Clinical and sociodemographic characteristics of Alzheimer's disease and related dementias among people with HIV.
    AIDS 2026;40:131.

  5. Kovalenko G, Liulchuk MG, Filippovych M, Smyrnov P, et al.
    VANTAGE: van-based real-time HIV sequencing for transmission mapping and drug resistance profiling in war-affected Ukraine.
    AIDS 2026;40:123-126.

  6. Freitas C, Cooper CL, Kroch AE, Buchan SA, et al.
    SARS-CoV-2 breakthrough infection among people with and without HIV in Ontario, Canada.
    AIDS 2026;40:119-122.

  7. Chan PA, Mena L, Maynard MA.
    Long-acting injectable lenacapavir for HIV prevention: clinical considerations during implementation.
    AIDS 2026;40:116-118.

  8. Domingo P, Stapleton JT.
    The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization.
    AIDS 2026;40:111-113.

  9. Makinson A, Bani-Sadr F, Palich R, Montes B, et al.
    Switch to BIC/TAF/FTC or DTG + TDF/FTC in virologically suppressed PWH: outcomes in real-world setting with and without tenofovir resistance.
    Clin Infect Dis 2026.

  10. .
    Correction to: Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
    Clin Infect Dis 2026.

  11. Solomon SS.
    When Programs Vanish: The Unseen Consequences.
    Clin Infect Dis 2026.

  12. Appa A, Steiner G, Baral S, Riley E, et al.
    Integrating HIV and Stimulant Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV Care.
    Clin Infect Dis 2026.

  13. Adamson PC, David HM, Pham LQ, Bui HTM, et al.
    Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam.
    Clin Infect Dis 2026;81:S231-S237.

  14. Fagan L, Alexander S, Fifer H.
    The Invisible Tide of Neisseria gonorrhoeae Treatment Failures: A Review and Commentary.
    Clin Infect Dis 2026;81:S223-S230.

  15. Thu NTM, Brown L, Hawkins O, Bloss K, et al.
    Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis.
    Clin Infect Dis 2026.

  16. Surmont M, Verheyden M, Sahebali S, Goossens M, et al.
    HPV-Related Anal Precancerous Lesions in MSM: A Comparative Study of PrEP Users and HIV-Positive Individuals.
    Clin Infect Dis 2026.

  17. Obeng BM, Hutchinson J, Shaik A, Chetchotisakd P, et al.
    Regional variations of rates and determinants of drug resistance mutations in people failing first-line therapy for HIV-1: a substudy from the D2EFT phase 3b/4 clinical trial.
    Clin Infect Dis 2026.

  18. Rose MR, Flexner C, Roy V.
    Subscription-Based Pricing for Lenacapavir-Learning From Hepatitis C and Cabotegravir.
    JAMA 2026.

  19. Kimmel AD, Stirratt M, Byrd KK, Bono RS, et al.
    The trials of insurance-based Data to Care-Rx: Low enrollment in the Antiretroviral Improvement among Medicaid enrolleeS (AIMS) study.
    J Acquir Immune Defic Syndr 2026.

  20. Baker P, Xiao J, Ma Y, He B, et al.
    The Role of Ryan White HIV/AIDS Program Services in Sustaining Viral Suppression Among People Living with HIV: Insights from South Carolina.
    J Acquir Immune Defic Syndr 2026.

  21. Broedlow CA, McGaugh A, Glynn TR, Cherenack EM, et al.
    Douching Is Associated With Dysregulated Rectal Mucosal Immunity in Sexual Minority Men.
    J Infect Dis 2026.

  22. Kankaka EN, Tomusange S, Kityamuweesi T, Quiros G, et al.
    Estimating HIV-1 Viremic Time from Reservoir Sequence Diversity with Uncertainty Quantification.
    J Infect Dis 2026.

  23. Blaauw MJT, Navas A, Vasquez VR, Vadaq N, et al.
    Functional and transcriptional senescence profiles of CD8+ T cells associate with the presence of carotid plaques in people living with HIV.
    J Infect Dis 2026.

  24. Ito Y, Hoeltermann TA, Anjum S, Robinson L, et al.
    Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series.
    J Infect Dis 2026.

  25. Wei-Ling Y, Na X, Lin L, Yu-Ting Z, et al.
    Endogenous HIV-1 Tat Promotes Cell Proliferation, Migration, and Phagocytosis in Stably Infected Macrophages by Accumulating Lactate and Activating the Autophagy/MAPK Pathway.
    J Med Virol 2026;98:e70788.

  26. Biswas U, Bernal C, Wang R, DeStefano JJ, et al.
    Correction for Biswas et al., "A novel aptamer-based dNTP assay reveals that intact HIV virions are highly stable and do not contain enough dNTPs to support DNA synthesis".
    J Virol 2026.

  27. Izu A, Koen A, Jose L, Cutland C, et al.
    Persistence of Antibodies at Three, Four and Five Years of Age to Ten-valent Pneumococcal Polysaccharide Protein D-conjugate Vaccine in South African Children According to HIV Status.
    Pediatr Infect Dis J 2026;45:173-180.

  28. Quan V, Meiring S, Mashau R, Perovic O, et al.
    Maternal-infant Characteristics of Preterm and Term Neonates With Bloodstream Infections in Lower-tier Hospitals in South Africa: A Cross-sectional Study.
    Pediatr Infect Dis J 2026.

  29. Ndjolo Ada ML, Fokam J, Kamgaing N, Ambe Chenwi C, et al.
    Low Rates of Virological Failure and Acquired HIV-1 Drug Resistance Among Children in Cameroon: Evidence Following Transition to Dolutegravir-based Regimens in Pediatrics.
    Pediatr Infect Dis J 2026.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

09 February 2026

02 February 2026

26 January 2026

19 January 2026

12 January 2026


12 January 2026

Multidisciplinary Journal Club

    No data available 2026-01-12.


Privacy Policy